【醫華生技 國際佈局】攜手中東生醫領袖 共同推動精準醫療新未來 🇦🇪🔬

醫華生技（CytoAurora Biotechnologies）國際拓展再傳捷報！

日前，醫華生技創辦人暨執行長 黃崇爾博士（Dr. Chung-Er Huang） 特別與 阿聯酋藥學會（Emirates Pharmacy Society）主席 Dr. Abdulla Al Kindi 展開高層會晤。

雙方針對先進細胞分析技術、癌症精準診斷，以及創新生物醫學發展進行了深入的經驗交流與合作探討。本次交流不僅深化了台灣生醫技術在中東市場的能見度，也為未來在杜拜及阿聯酋地區的醫療創新合作奠定了堅實基礎。

醫華生技將持續以突破性的單細胞分析與精準醫療科技，連結全球醫療資源，為人類健康帶來更多希望與可能！

We are honored to share that Dr. Chung-Er Huang, PhD, Founder & CEO of CytoAurora Biotechnologies, recently met with Dr. Abdulla Al Kindi, President of the Emirates Pharmacy Society.

During this strategic meeting, both parties explored prospective collaborations and knowledge exchanges in:

🔬 Advanced Cell Analysis & Diagnostics

🎯 Precision Medicine & Cancer Care

🧬 Innovative Biomedical Technologies

As CytoAurora continues to expand its global footprint, we remain dedicated to bringing our cutting-edge bio-technologies to the Middle East, empowering healthcare providers, and improving patient outcomes worldwide.

A sincere thank you to Dr. Abdulla Al Kindi and the Emirates Health Services team for fostering an inspiring dialogue on the future of healthcare innovation.

#CytoAurora #Biotechnology #PrecisionMedicine #CancerDiagnostics #CellAnalysis #EmiratesPharmacySociety #DubaiHealthcare #HealthcareInnovation #GlobalExpansion